New Breakthrough: Intranasal Nano-Ivermectin Reduces Brain Tumors by 70% in Preclinical Study
A groundbreaking preclinical study found that intranasal nano-encapsulated ivermectin safely shrank glioblastoma tumors by up to 70% in animal models.
A groundbreaking preclinical study found that intranasal nano-encapsulated ivermectin safely shrank glioblastoma tumors by up to 70% in animal models.
Want to dine out without compromising your health? The Templeton List reveals restaurants across America that prioritize clean ingredients, thoughtful preparation, farm-to-table sourcing, and menus that support a health-conscious lifestyle.